Development of Chemically-Defined Platform Materials for Localized Delivery of RNA Therapeutics
Most nucleic acid therapeutics have been engineered for systemic delivery with accumulation predominantly occurring in the liver. Currently, mRNA and siRNA represent the most clinically advanced nucleic acid modalities which can be used to address underlying under- or over-expression of crucial prot...
Main Author: | Andresen, Jason Lee |
---|---|
Other Authors: | Langer, Robert |
Format: | Thesis |
Published: |
Massachusetts Institute of Technology
2024
|
Online Access: | https://hdl.handle.net/1721.1/154211 |
Similar Items
-
Tumor-penetrating delivery of small interfering RNA therapeutics
by: Ren, Yin, Ph. D. Massachusetts Institute of Technology
Published: (2012) -
Development and evaluation of chemical modifications and conjugations for nucleic acid therapeutic delivery
by: Nguyen, Minh Duc
Published: (2023) -
Advances in the delivery of RNA therapeutics: from concept to clinical reality
by: Kaczmarek, James Cliff, et al.
Published: (2017) -
The Pivotal Role of Chemical Modifications in mRNA Therapeutics
by: Liu, Albert, et al.
Published: (2022) -
Delivery of therapeutic carbon monoxide by gas-entrapping materials
by: Byrne, James D., et al.
Published: (2024)